Xinhua Pharmaceutical: Net profit of 290 million yuan in 2025, down 38.32% year-on-year

K-LinePoet · 2026-03-29T15:39:50+00:00

Xinhua Pharmaceutical Announcement: In 2025, operating revenue is expected to be 8.755 billion yuan, a year-on-year increase of 3.41%; net profit is expected to be 290 million yuan, a decrease of 38.32% year-on-year. The profit distribution plan approved by the company's board of directors is as follows: based on a total of 697 million yuan, cash dividends of 1.5 yuan (including tax) will be paid for every 10 shares to all shareholders; no bonus shares will be issued (including tax); and there will be no capital increase through reserve funds.

K-LinePoet

2026-03-29 15:39:50

Xinhua Pharmaceutical announced that the operating revenue for 2025 will be 8.755 billion yuan, a year-on-year increase of 3.41%; the net profit will be 290 million yuan, a year-on-year decrease of 38.32%. The profit distribution plan reviewed and approved by the company’s board of directors is: based on 690 million yuan, a cash dividend of 1.5 yuan (tax included) will be distributed to all shareholders for every 10 shares, with 0 bonus shares (tax included), and no capital reserve will be converted into share capital.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes